Neuropsychopharmacology ReportsAim Psychopharmacotherapy plays an important role in the treatment of mentally disordered offenders (MDOs) with schizophrenia spectrum disorders. However, there have been few large‐scale reports from multiple forensic psychiatric wards.
Koji Takeda +9 more
doaj +2 more sources
Global Functioning and Mental Health Parameters: Examining Interplay and Improvements in Inpatient Psychiatry. [PDF]
Int J Methods Psychiatr ResABSTRACT Introduction Global functioning is a common clinician‐rated measure of treatment changes in inpatient psychiatric care, but its broad scope may limit its sensitivity to specific mental health changes. This study aimed to research interplay and improvements of global functioning and several mental health parameters.
Finner A +12 more
europepmc +2 more sources
Sexual dimorphism and specificities of psychopharmacological treatment in women [PDF]
Srpski Arhiv za Celokupno Lekarstvo, 2013 The scope of gender related differences observed in mentally ill persons provides a major source of inference about the role of gonadal steroids in brain function and behavior.
Draganić-Gajić Saveta +4 more
doaj +1 more source
The group-based social skills training SOSTA-FRA in children and adolescents with high functioning autism spectrum disorder - study protocol of the randomised, multi-centre controlled SOSTA - net trial [PDF]
, 2013 Background: Group-based social skills training (SST) has repeatedly been recommended as treatment of choice in high-functioning autism spectrum disorder (HFASD). To date, no sufficiently powered randomised controlled trial has been performed to establish
Bender, Stephan +6 more
core +1 more source
Clinical Effectiveness of Lurasidone Monotherapy in Patients with Acute Episodes of Schizophrenia and Associated Symptoms of Depression [PDF]
Consortium Psychiatricum, 2022 AIM: We endeavored to evaluate the efficacy of Lurasidone at doses of 40160 mg per day on symptoms of schizophrenia associated with symptoms of depression in real clinical practice in a Russian patient population.
Alexander M. Reznik +16 more
doaj +1 more source
Sensitivity to social exclusion in major depressive disorder (MDD) predicts therapeutic outcome after in-patient treatment [PDF]
, 2016 A
De Rubeis, J +4 more
core +2 more sources
Научно-практическая ревматология, 2018 Mental disorders (MDs) of the anxiety-depressive spectrum (ADS) and cognitive impairment (CI) substantially deteriorate the course and efficiency of therapy for rheumatoid arthritis (RA).
A. A. Abramkin +5 more
doaj +1 more source
A chronobiological approach to therapy for depression
Неврология, нейропсихиатрия, психосоматика, 2017 In the modern world, the discrepancy between biological and social rhythms in the presence of the existing genetic predisposition increases a risk for the occurrence and chronicity of depression.
M. Yu. Gerasimchuk
doaj +1 more source
Особенности психофармакотерапии пациентов с коронавирусной инфекцией (COVID-19)
Современная терапия психических расстройств, 2020 В статье описаны особенности психофармакотерапии пациентов с психическими расстроиствами,заболевших коронавируснои инфекциеи(COVID19).Актуальность этои темы определяется ситуациеи нарастающеи эпидемии в России и имеющимся опытом Китая и Италии,по ...
Костюкова, Е.Г. +3 more
doaj +1 more source
Mirroring everyday clinical practice in clinical trial design: a new concept to improve the external validity of randomized double-blind placebo-controlled trials in the pharmacological treatment of major depression [PDF]
, 2012 Background: Randomized, double-blind, placebo-controlled trials constitute the gold standard in clinical research when testing the efficacy of new psychopharmacological interventions in the treatment of major depression.
A Cipriani +43 more
core +3 more sources